Table: begin end state 1 29 cytoplasmic 30 48 transmembrane 49 53 non-cytoplasmic 54 78 transmembrane 79 89 cytoplasmic 90 110 transmembrane 111 116 non-cytoplasmic 117 142 transmembrane 143 154 cytoplasmic 155 178 transmembrane 179 190 non-cytoplasmic 191 212 transmembrane 213 242 cytoplasmic 243 265 transmembrane 266 276 non-cytoplasmic 277 300 transmembrane 301 308 cytoplasmic 309 328 transmembrane 329 333 non-cytoplasmic 334 358 transmembrane 359 371 cytoplasmic 372 394 transmembrane 395 399 non-cytoplasmic 400 421 transmembrane 422 437 cytoplasmic
Input: >BPHYT_RS07110 MNREQDDHAAGRQPTRAAAAAFVGTTIEWYDFYIYATASALIFGKLFFPGSDPFFATLAS FGTFAVGFFARPFGGLVFGHLGDRIGRKKALVATLAIMGVGTVGIGFLPTYASAGVWAPV LLVLLRVAQGIAIGGEWGGAVLMASEHAPQGRRTFFASFAQLGSPAGLILSLLAFRAVAS MDKDAFLGWGWRLPFLASAVLLVVGLLIRAGVDESPEFKALKAQRRVAALPVAEVVRDAW RTLLLCLGANVIGVAGAWFVNTFMLNYTTQTLGLDRSLILDCLFVVAFIQLFTQLGSGWF AQRIGTGRFLKGAAALAMLSPYPMFALVSTGRPVAIVIGIALAVMCMSSSYAVMAGFMST AFPVRVRYSAISLSYQVCAALAGGLTPLIGTLLAHRYPGAWWPLAVFYSVLAGVSLVCIG TLERRKRGAAHGVVEAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server